In her career spanning more than 25 years, Dr. Shatin has successfully served diverse health care organizations, including federal agencies and funders (FDA, AHRQ, CDC,CMS), corporations (drug and device companies), health care provider organizations (IPA and staff models), physician specialties (cardiovascular, neurosurgeons,orthopedic, vascular surgeons), and academic health settings throughout the US. In addition to her research in both medical device and pharmaceutical therapies and in the commercial payer market, she has served as Industry Representative to an FDA CDRH review panel, the CMS Medicare Coverage Advisory Committee (now MEDCAC), and as a consultant to the FDA Drug Safety and Risk Management Committee.
Self-managed web sites powered by iEditWeb, Inc.